A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database

Tirofiban, as a GP IIb/IIIa receptor antagonist, competitively inhibits the bridging of platelets via fibrin, which is the…
#NewsBeep #News #Headlines #Adverseevent #bleeding #cardiology #Disproportionalityanalysis #FAERS #HumanitiesandSocialSciences #Latvia #LV #Medicalresearch #multidisciplinary #Neurology #Science #Tirofiban
https://www.newsbeep.com/95720/

Un estudio chino de Pekín (el origen no es importante, pero me encanta como suena “chino de Pekín” 😋), #TREND, mostró que el uso del #antiplaquetario endovenoso #Tirofibán redujo la incidencia de empeoramiento en pacientes con #EVC isquémico en pacientes que no fueron candidatos a #trombolisis, comparado con aspirina (lo que usamos actualmente).

Por fin tenemos alternativas!!

#Neurology #Stroke #Antiplatelet #Neurología

https://www.medscape.com/viewarticle/tirofiban-reduces-early-neurologic-deterioration-after-2024a10002yk

Tirofiban Reduces Early Neurologic Deterioration After Stroke

Intravenous tirofiban over 72 hours reduced early neurologic deterioration compared with oral aspirin in patients with acute ischemic stroke, in the randomized TREND trial.

Medscape
Tirofiban Reduces Early Neurologic Deterioration After Stroke

Intravenous tirofiban over 72 hours reduced early neurologic deterioration compared with oral aspirin in patients with acute ischemic stroke, in the randomized TREND trial.

Medscape